SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-219184
Filing Date
2020-08-13
Accepted
2020-08-13 16:30:53
Documents
3
Period of Report
2020-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d83225d8k.htm 8-K 17770
2 EX-99.1 d83225dex991.htm EX-99.1 45528
3 GRAPHIC g83225dsp4.jpg GRAPHIC 10355
  Complete submission text file 0001193125-20-219184.txt   73457
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 201099763
SIC: 2834 Pharmaceutical Preparations